Ipsen acquires Memo Therapeutics, a portfolio company of Ysios Capital

by Ysios Capital

Under the terms of the agreements, shareholders of Memo Therapeutics AG will receive a 200 million EUR payment on a cash-free and debt-free basis at closing of the transaction, and deferred payments c...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Kenta Capital Advises Greenalia on the D...

by Kenta Capital

Kenta Capital, the debt advisory firm specialising in alternative fina...

Photos Stream